- Healthcare 150
- Posts
- Why AI in Healthcare Isn’t Experimental Anymore
Why AI in Healthcare Isn’t Experimental Anymore
It’s Thursday and we’re diving into AI’s growing share in digital health, the healthcare’s fax machine problem, and the global healthcare workforce shortfall.
In partnership with
Good morning, ! It’s Thursday and we’re diving into AI’s growing share in digital health, the healthcare’s fax machine problem, and the global healthcare workforce shortfall.
First time reading? Join healthcare execs and innovators who rely on Healthcare150 for sharp, data-driven insights. Subscribe here.
Know someone in the healthcare space who should see this? Forward it their way. Here’s the link.
— The Healthcare150 Team
DATA DIVE
AI’s White Coat Moment
AI isn’t a feature anymore—it’s the framework. In 2024, AI-enabled healthtech startups pulled in 42% of all digital health funding, no longer pitching futuristic dreams but embedding into clinical decision support and diagnostics. Sword Health hit a $3B valuation. Eko Health raised $41M to supercharge cardiac screening. The kicker? AI is no longer optional—it’s the table stakes for care delivery infrastructure. For investors: clinical outcomes, regulatory clearance, and proprietary data are the new hype. Everyone else? See you in the pilot program graveyard. (Read or Listen to the Full Report)
TREND OF THE WEEK
Healthcare’s Fax Machine Problem Is Finally Getting Addressed
Digital transformation is finally breaking into healthcare with the kind of urgency that most industries adopted... last decade. In 2025, 90% of global health executives expect it to have a significant impact, making it the top strategic concern. Translation: the days of fax machines and manual workflows may finally be numbered. Still, transformation isn’t just about shiny dashboards—78% say cybersecurity is priority #1, followed by upgrades to tech platforms (72%) and core systems like EMRs and ERP (60%). As AI and virtual care mature, the real pivot is this: digital is no longer a “pilot” program—it’s the new baseline. (More)
PRESENTED BY BILL
Hear why BILL S&E is #1 + earn AirPods 4
BILL is the all-in-one financial platform that simplifies managing bills, invoices, expenses, budgets, and business credit.
As a controller, you need software that works as hard as you do—that’s why BILL Spend & Expense is ranked #1 on G2’s 2025 Best Accounting & Finance Products list. New features include:
Assistant permissions for seamless delegation
Auto-freezing cards
Visa Signature benefit
API integrations for smarter scaling
Ready to see it in action and claim your AirPods 4?*
*Terms and conditions apply. See offer page for details. The BILL Divvy Card is issued by Cross River Bank, Member FDIC, and is not a deposit product.
MARKET MOVERS
Company (Ticker) | Last Price | 5D |
Eli Lilly and Company (LLY) | $ 752.83 | -8.02% |
Johnson & Johnson (JNJ) | $ 150.52 | -2.56% |
Novo Nordisk A/S (NVO) | $ 65.72 | -0.77% |
Roche Holding AG (ROG.SW) | $ 258.8 | -4.64% |
AbbVie Inc. (ABBV) | $ 186.05 | -0.27% |
HEALTHTECH CORNER
Hong Kong Gets a HealthTech Upgrade
MedTech World and NovaX Global are taking their show on the road—straight to Hong Kong, the investment-packed gateway to Asia’s $1.7T healthcare market. From June 30 to July 1, the 2025 Roadshow will bring together startups, investors, and MedTech leaders in a city where you can pitch a VC in the morning and be in Shanghai by lunch. Backed by $200B in VC firepower, 400+ local health startups, and fast-track regulatory pathways (MDACS + China’s NMPA), this is no vanity play.
It’s a calculated strike into the heart of Asia’s growth corridor. If last year’s 10,000-attendee Investmatch Carnival was any sign, expect high volume and serious capital looking for a home. Bottom line: Hong Kong just became the next big checkpoint for anyone betting on global HealthTech scale. (More)
TOGETHER WITH SCOTTS TENNIS
EXPERIENCE | Where Tennis Meets Strategy
Two luxury events. One clear takeaway: elite experiences are becoming a new channel for high-level networking and brand alignment in the PE ecosystem.
The Stuttgart Experience (June 12–15) places you at the center of the BOSS Open with VIP access, fine dining, and a once-in-a-lifetime ProAm match alongside Tommy Haas. Off the court, expect curated cultural perks—private museum tours (Porsche, Mercedes-Benz), and a tailored shopping session at the BOSS flagship in Metzingen.
The Mallorca Championships (June 25–28) double down on tennis and tranquility. Watch world-class players from premium seats, tour behind-the-scenes with tournament insiders, and cruise the Balearic coast by private boat. The itinerary includes a visit to the Rafa Nadal Academy and a rare audience with Toni Nadal—plus a stay at the 5-star Kimpton Mallorca.
More than a hospitality package, each experience creates space for meaningful conversations, strategic connections, and lasting impressions—on and off the court.
To learn more or reserve your spot, email: [email protected]
DEAL OF THE WEEK
Bain Dives Deep into Pharma
Bain Capital is nearing a $10B acquisition of PCI Pharma Services, making it one of 2025’s largest healthcare buyouts. PCI specializes in pharma packaging and sterile fill-finish, particularly for blockbuster drugs like GLP-1-based obesity treatments (yes, think Wegovy). The deal includes backing from Blue Owl’s $3B unitranche facility and brings in heavyweight co-investors, including sovereign wealth funds. PCI’s current backers — Kohlberg, Mubadala, and Partners Group — are engaged in talks. This would mark a significant scale-up from Bain’s 2023 minority stake in Zelis. If it closes, Bain won’t just be making pills easier to ship — it’ll be putting itself squarely in the high-demand path of weight-loss megatrends. (More)
TOGETHER WITH 1440 MEDIA
Fact-based news without bias awaits. Make 1440 your choice today.
Overwhelmed by biased news? Cut through the clutter and get straight facts with your daily 1440 digest. From politics to sports, join millions who start their day informed.
REGIONAL FOCUS
Global Healthcare Workforce: The Shortfall by Region
The global healthcare workforce is grappling with a staggering shortfall, nearly 53 million workers are needed to meet demand. While supply trails demand everywhere, some regions face steeper gaps than others, revealing the contours of a mounting global healthcare crisis.
Southeast Asia and the Western Pacific are under the heaviest strain, needing 14.7M and 12.3M additional workers, respectively, to close the gap. Even Europe, which boasts the second-highest supply globally, faces a deficit of 5.8M workers. In the Eastern Mediterranean and the Americas, gaps of over 5M and 6M highlight the uneven healthcare infrastructure despite significant demand.
Surprisingly, Africa shows a surplus on paper, with supply exceeding demand, but the region still reports the highest overall need (8.9M), hinting at structural underestimation and deeper systemic challenges.
INTERESTING ARTICLES